Found 263 results
[ Author(Desc)] Keyword Title Type Year
Filters: First Letter Of Keyword is F  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
J
Johnson LA, Zuloaga KL, Kugelman TL, Mader KS, Morré JT, Zuloaga DG, Weber S, Marzulla T, Mulford A, Button D et al..  2016.  Amelioration of Metabolic Syndrome-Associated Cognitive Impairments in Mice via a Reduction in Dietary Fat Content or Infusion of Non-Diabetic Plasma.. EBioMedicine. 3:26-42.
Jubert C, Mata J, Bench G, Dashwood R, Pereira C, Tracewell W, Turteltaub K, Williams D, Bailey G.  2009.  Effects of chlorophyll and chlorophyllin on low-dose aflatoxin B(1) pharmacokinetics in human volunteers.. Cancer Prev Res (Phila). 2(12):1015-22.
Jump DB.  2011.  Fatty acid regulation of hepatic lipid metabolism.. Curr Opin Clin Nutr Metab Care. 14(2):115-20.
Jump DB, Depner CM, Tripathy S.  2012.  Omega-3 fatty acid supplementation and cardiovascular disease.. J Lipid Res. 53(12):2525-45.
Jump DB, Tripathy S, Depner CM.  2013.  Fatty acid-regulated transcription factors in the liver.. Annu Rev Nutr. 33:249-69.
Jump DB, Depner CM, Tripathy S, Lytle KA.  2015.  Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.. Adv Nutr. 6(6):694-702.
Jump DB.  2008.  N-3 polyunsaturated fatty acid regulation of hepatic gene transcription.. Curr Opin Lipidol. 19(3):242-7.
Jump DB, Depner CM, Tripathy S, Lytle KA.  2015.  Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.. Adv Nutr. 6(6):694-702.
Jump DB, Torres-Gonzalez M, L Olson K.  2011.  Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation.. Biochem Pharmacol. 81(5):649-60.
Jump DB, Torres-Gonzalez M, L Olson K.  2011.  Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation.. Biochem Pharmacol. 81(5):649-60.
Jump DB.  2011.  Fatty acid regulation of hepatic lipid metabolism.. Curr Opin Clin Nutr Metab Care. 14(2):115-20.
Jump DB, Tripathy S, Depner CM.  2013.  Fatty acid-regulated transcription factors in the liver.. Annu Rev Nutr. 33:249-69.
K
Kacsóh B, Tóth BE, Avery LM, Grosvenor CE.  1993.  In vitro control of prolactin (PRL) and growth hormone secretion of neonatal rat pituitary glands: effects of ovine PRL, salmon calcitonin, endothelin-3, angiotensin II, bromocryptine and somatostatin.. Life Sci. 52(3):259-69.
Keith DJ, Butler JA, Bemer B, Dixon B, Johnson S, Garrard M, Sudakin DL, J Christensen M, Pereira C, Hagen TM.  2012.  Age and gender dependent bioavailability of R- and R,S-α-lipoic acid: a pilot study.. Pharmacol Res. 66(3):199-206.
Kerr DCR, Zava DT, Piper WT, Saturn SR, Frei B, Gombart AF.  2015.  Associations between vitamin D levels and depressive symptoms in healthy young adult women.. Psychiatry Res. 227(1):46-51.
Kesinger NG, Stevens JF.  2009.  Covalent interaction of ascorbic acid with natural products.. Phytochemistry. 70(17-18):1930-9.
Khorani M, Bobe G, Matthews DG, Magana AAlcazar, Caruso M, Gray NE, Quinn JF, Stevens JF, Soumyanath A, Maier CS.  2022.  The Impact of the hAPP695SW Transgene and Associated Amyloid-β Accumulation on Murine Hippocampal Biochemical Pathways.. J Alzheimers Dis. 85(4):1601-1619.
Kirkwood JS, Legette LCL, Miranda CL, Jiang Y, Stevens JF.  2013.  A metabolomics-driven elucidation of the anti-obesity mechanisms of xanthohumol.. J Biol Chem. 288(26):19000-13.
Kirkwood JS, Maier C, Stevens JF.  2013.  Simultaneous, untargeted metabolic profiling of polar and nonpolar metabolites by LC-Q-TOF mass spectrometry.. Curr Protoc Toxicol. Chapter 4:Unit4.39.
Kirkwood JS, Legette LCL, Miranda CL, Jiang Y, Stevens JF.  2013.  A metabolomics-driven elucidation of the anti-obesity mechanisms of xanthohumol.. J Biol Chem. 288(26):19000-13.
Krueger SK, Martin SR, Yueh M-F, Pereira CB, Williams DE.  2002.  Identification of active flavin-containing monooxygenase isoform 2 in human lung and characterization of expressed protein.. Drug Metab Dispos. 30(1):34-41.
Krueger SK, VanDyke JE, Williams DE, Hines RN.  2006.  The role of flavin-containing monooxygenase (FMO) in the metabolism of tamoxifen and other tertiary amines.. Drug Metab Rev. 38(1-2):139-47.
Kuiper HC, Bruno RS, Traber MG, Stevens JF.  2011.  Vitamin C supplementation lowers urinary levels of 4-hydroperoxy-2-nonenal metabolites in humans.. Free Radic Biol Med. 50(7):848-53.
Kuiper HC, Langsdorf BL, Miranda CL, Joss J, Jubert C, Mata JE, Stevens JF.  2010.  Quantitation of mercapturic acid conjugates of 4-hydroxy-2-nonenal and 4-oxo-2-nonenal metabolites in a smoking cessation study.. Free Radic Biol Med. 48(1):65-72.
Kuschner CE, Choi J, Yin T, Shinozaki K, Becker LB, Lampe JW, Kim J.  2018.  Comparing phospholipid profiles of mitochondria and whole tissue: Higher PUFA content in mitochondria is driven by increased phosphatidylcholine unsaturation.. J Chromatogr B Analyt Technol Biomed Life Sci. 1093-1094:147-157.

Pages